Chavez ML. Glucosamine sulfate and chondroitin sulfates. Hosp Pharm 1997;32:1275-85.
Chu EC, Huang KHK, Cheung G, Ng G, Lin A. Delayed Skin Allergy to Glucosamine Chondroitin Supplement. Cureus 2023;15(3):e36310. View abstract.
Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006;354:795-808. View abstract.
Cohen M, Wolfe R, Mai T, Lewis D. A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee. J Rheumatol 2003;30:523-8.. View abstract.
Conrozier T. [Anti-arthrosis treatments: efficacy and tolerance of chondroitin sulfates]. Presse Med 1998;27:1862-5. View abstract.
Conte A, de Bernardi M, Palmieri L, et al. Metabolic fate of exogenous chondroitin sulfate in man. Arzneimittelforschung 1991; 41:768-72. View abstract.
Danao-Camara T. Potential side effects of treatment with glucosamine and chondroitin. Arthritis Rheum 2000;43:2853. View abstract.
Das A Jr, Hammad TA. Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage 2000;8:343-50. View abstract.
De Vita D, Antell H, Giordano S. Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: a meta-analysis. Int Urogynecol J 2013;24(4):545-52. View abstract.
Di Caro A, Perola E, Bartolini B, et al. Fractions of chemically oversulphated galactosaminoglycan sulphates inhibit three enveloped viruses: human immunodeficiency virus type 1, herpes simplex virus type 1 and human cytomegalovirus. Antivir Chem Chemother 1999;10:33-8.. View abstract.
FDA grants premarket approval for Viscoat. Biomed Safety Standards 1986;16(11):82.
FDA. Premarket Approval (PMA). Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=20196.
Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002. Available at: www.nap.edu/books/0309072794/html/.
Fransen M, Agaliotis M, Nairn L, Votrubec M, Bridgett L, Su S, Jan S, March L,Edmonds J, Norton R, Woodward M, Day R; LEGS study collaborative group. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis 2015;74(5):851-8. View abstract.
Gabay C, Medinger-Sadowski C, Gascon D, et al. Symptomatic effect of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center. Arthritis Rheum 2011;63:3383-91. View abstract.
Goddard JC, Janssen DAW. Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis. Int Urogynecol J. 2018 Jul;29(7):933-942. Epub 2017 Nov 27. Review. View abstract.
Greenlee H, Crew KD, Shao T, Kranwinkel G, Kalinsky K, Maurer M, Brafman L, Insel B, Tsai WY, Hershman DL. Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer. Support Care Cancer 2013;21(4):1077-87. View abstract.
Honvo G, Bruyère O, Geerinck A, Veronese N, Reginster JY. Efficacy of chondroitin sulfate in patients with knee osteoarthritis: A comprehensive meta-analysis exploring inconsistencies in randomized, placebo-controlled trials. Adv Ther. 2019;36(5):1085-1099. View abstract.
Huang J, Olivenstein R, Taha R, et al. Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med 1999;160:725-9. View abstract.
Iannitti T, Morales-Medina JC, Merighi A, et al. A hyaluronic acid- and chondroitin sulfate-based medical device improves gastritis pain, discomfort, and endoscopic features. Drug Deliv Transl Res. 2018 Oct;8(5):994-999. View abstract.
Jackson, C. G., Plaas, A. H., Sandy, J. D., Hua, C., Kim-Rolands, S., Barnhill, J. G., Harris, C. L., and Clegg, D. O. The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination. Osteoarthritis Cartilage 2010;18(3):297-302. View abstract.
Jurkiewicz E, Panse P, Jentsch KD, et al. In vitro anti-HIV-1 activity of chondroitin polysulphate. AIDS 1989;3:423-7. View abstract.
Kahan A. STOPP (STudy on Osteoarthritis Progression Prevention): a new two-year trial with chondroitin 4&6 sulfate (CS). Available at: www.ibsa-ch.com/eular_2006_amsterdam_vignon-2.pdf (Accessed 25 April 2007).
Kalman DS, Schwartz HI, Pachon J, Sheldon E, Almada AL. A randomized double blind clinical pilot trial evaluating the safety and efficacy of hydrolyzed collagen type II in adults with osteoarthritis. FASEB Experimental Biology 2004 Abstracts, Washington DC, April 17-21, 2004; A90.
Kelly GS. The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease. Altern Med Rev 1998;3:27-39. View abstract.
King DE, Xiang J. Glucosamine/Chondroitin and Mortality in a US NHANES Cohort. J Am Board Fam Med. 2020;33(6):842-847. View abstract.
Knudsen J, Sokol GH. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: Case report and review of the literature and MedWatch database. Pharmacotherapy 2008;28:540-8. View abstract.
Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020 Feb;72(2):220-33. View abstract.
Lauder RM. Chondroitin sulphate: a complex molecule with potential impacts on a wide range of biological systems. Complement Ther Med 2009;17(1):56-62. View abstract.
Altman, A. J., Albert, D. M., and Fournier, G. A. Cocaine's use in ophthalmology: our 100-year heritage. Surv.Ophthalmol. 1985;29(4):300-306. View abstract.
Bedford, J. A., Turner, C. E., and elSohly, H. N. Local anesthetic effects of cocaine and several extracts of the coca leaf (E. coca). Pharmacol.Biochem.Behav. 1984;20(5):819-821. View abstract.
Bieri, S., Ilias, Y., Bicchi, C., Veuthey, J. L., and Christen, P. Focused microwave-assisted extraction combined with solid-phase microextraction and gas chromatography-mass spectrometry for the selective analysis of cocaine from coca leaves. J Chromatogr.A 4-21-2006;1112(1-2):127-132. View abstract.
Borghelli, R. F., Stirparo, M. A., Andrade, J. H., Centofanti, M. H., and Barros, R. E. [Lesions of the oral mucosa caused by the use of coca leaves (Erythroxyloncoca) in 20 year old men in the Province of Jujuy (Argentina)]. Rev.Asoc.Odontol.Argent 1973;61(7):250-254. View abstract.
Borghelli, R. F., Stirparo, M., Andrade, J., Barros, R., Centofanti, M., and de Estevez, O. T. Leukoedema in addicts to coca leaves in Humahuaca, Argentina. Community Dent.Oral Epidemiol. 1975;3(1):40-43. View abstract.
Calatayud, J. and Gonzalez, A. History of the development and evolution of local anesthesia since the coca leaf. Anesthesiology 2003;98(6):1503-1508. View abstract.
Casale, J. F. and Moore, J. M. Detection and determination of pseudococaine in coca leaves and illicit cocaine samples. J Forensic Sci 1994;39(6):1537-1543. View abstract.
Dagnino, J. Coca leaf and local anesthesia. Anesthesiology 2004;100(5):1322. View abstract.
Fairley, H. B. [Anesthesia in the Inca empire]. Rev.Esp.Anestesiol.Reanim. 2007;54(9):556-562. View abstract.
Favier, R., Caceres, E., Koubi, H., Sempore, B., Sauvain, M., and Spielvogel, H. Effects of coca chewing on hormonal and metabolic responses during prolonged submaximal exercise. J.Appl.Physiol 1996;80(2):650-655. View abstract.
Galarza, Guzman M., Penaloza, Imana R., Echalar, Afcha L., Aguilar, Valerio M., Spielvogel, H., and Sauvain, M. [Effects of coca chewing on the glucose tolerance test]. Medicina (B Aires) 1997;57(3):261-264. View abstract.
Grzybowski, A. [The history of cocaine in medicine and its importance to the discovery of the different forms of anaesthesia]. Klin.Oczna 2007;109(1-3):101-105. View abstract.
Grzybowski, A. Cocaine and the eye: a historical overview. Ophthalmologica 2008;222(5):296-301. View abstract.
Hanna, J. M. Further studies on the effects of coca chewing on exercise. Hum.Biol. 1971;43(2):200-209. View abstract.
Hanna, J. M. The effects of coca chewing on exercise in the Quechua of Peru. Hum.Biol. 1970;42(1):1-11. View abstract.
Harland, E. C., Murphy, J. C., Elsohly, H., Greubel, D., Turner, C. E., and Watson, E. S. Biological effects of nonalkaloid-containing fractions of Erythroxylon coca. J Pharm Sci 1982;71(6):677-679. View abstract.
Homstedt, B., Lindgren, J. E., Rivier, L., and Plowman, T. Cocaine in blood of coca chewers. J.Ethnopharmacol. 1979;1(1):69-78. View abstract.
Hurtado-Gumucio, J. Coca leaf chewing as therapy for cocaine maintenance. Ann.Med.Interne (Paris) 2000;151 Suppl B:B44-B48. View abstract.
Jenkins, A. J., Llosa, T., Montoya, I., and Cone, E. J. Identification and quantitation of alkaloids in coca tea. Forensic Sci.Int. 2-9-1996;77(3):179-189. View abstract.
Jozsa, L. [Dental care, dental diseases and dentistry in antiquity]. Orvostort.Kozl. 2009;55(1-4):43-57. View abstract.
Mazor, S. S., Mycyk, M. B., Wills, B. K., Brace, L. D., Gussow, L., and Erickson, T. Coca tea consumption causes positive urine cocaine assay. Eur.J Emerg.Med 2006;13(6):340-341. View abstract.
Middleton, R. M. and Kirkpatrick, M. B. Clinical use of cocaine. A review of the risks and benefits. Drug Saf 1993;9(3):212-217. View abstract.
Novak, M., Salemink, C. A., and Khan, I. Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatense. J Ethnopharmacol. 1984;10(3):261-274. View abstract.
Prance, G. The poisons and narcotics of the Amazonian Indians. J R.Coll.Physicians Lond 1999;33(4):368-376. View abstract.
Reisner, L. Biologic poisons for pain. Curr.Pain Headache Rep. 2004;8(6):427-434. View abstract.
Sharkey, J., Ritz, M. C., Schenden, J. A., Hanson, R. C., and Kuhar, M. J. Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J Pharmacol.Exp.Ther. 1988;246(3):1048-1052. View abstract.
Siegel, R. K. New patterns of cocaine use: changing doses and routes. NIDA Res.Monogr 1985;61:204-220. View abstract.
Spielvogel, H., Caceres, E., Koubi, H., Sempore, B., Sauvain, M., and Favier, R. Effects of coca chewing on metabolic and hormonal changes during graded incremental exercise to maximum. J.Appl.Physiol 1996;80(2):643-649. View abstract.
Weil, A. T. Coca leaf as a therapeutic agent. Am.J.Drug Alcohol Abuse 1978;5(1):75-86. View abstract.
Weil, A. T. The therapeutic value of coca in contemporary medicine. J.Ethnopharmacol. 1981;3(2-3):367-376. View abstract.
Alexandrakis G, Tse DT, Rosa RH Jr, Johnson TE. Nasolacrimal duct obstruction and orbital cellulitis associated with chronic intranasal cocaine abuse. Arch Ophthalmol 1999;117:1617-22. View abstract.
Bedford JA, Lovell DK, Turner CE, et al. The anorexic and actometric effects of cocaine and two coca extracts. Pharmacol Biochem Behav 1980;13:403-8.. View abstract.
Bedford JA, Nail GL, et al. Comparative stimulus properties of two fractions of the coca leaf (E. coca). Pharmacol Biochem Behav 1981;15:907-9.. View abstract.
Bolla KI, Funderburk FR, Cadet JL. Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology 2000;54:2285-92. View abstract.
Buck AA, Sasaki TT, Hewitt JJ, Macrae AA. Coca chewing and health. An epidemiologic study among residents of a Peruvian village. Am J Epidemiol 1968;88:159-77.. View abstract.
Caravedo MA, Mozo K, Morales ML, et al. Risk factors for acute mountain sickness in travelers to Cusco, Peru: coca leaves, obesity, and sex. J Travel Med. 2021 Jul 6:taab102. View abstract.
Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
Engelke BF, Gentner WA. Determination of cocaine in "Mate de Coca" herbal tea. J Pharm Sci 1991;80:96.. View abstract.
Favier R, Caceres E, Guillon L, et al. Coca chewing for exercise: hormonal and metabolic responses of nonhabitual chewers. J Appl Physiol 1996;81:1901-7.. View abstract.
Favier R, Caceres E, Sempore B, et al. Fluid regulatory hormone response to exercise after coca-induced body fluid shifts. J Appl Physiol 1997;83:376-82.. View abstract.
Galarza Guzman M, Penaloza Imana R, Echalar Afcha L, et al. Effects of coca chewing on glucose tolerance test. Medicina (B Aires) 1997;57(3):261-4. View abstract.
Heesch CM, Wilhelm CR, Ristich J, et al. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart 2000;83:688-95. View abstract.
Jackson GF, Saady JJ, Poklis A. Urinary excretion of benzoylecgonine following ingestion of Health Inca Tea. Forensic Sci Int 1991;49:57-64.. View abstract.
Mazor SS, Mycyk MB, Willis BK, et al. Coca tea consumption causes positive urine cocaine assay. Eur J Emerg Med 2006;13(6):340-1. View abstract.
McEvoy AW, Kitchen ND, Thomas DG. Intracerebral haemorrhage in young adults: the emerging importance of drug misuse. BMJ 2000;320:1322-4. View abstract.
Potter SM, Zelazo PR, Stack DM, Papageorgiou AN. Adverse effects of fetal cocaine exposure on neonatal auditory information processing. Pediatrics 2000;105:E40.. View abstract.
Roldan CA, Aliabadi D, Crawford MH. Prevalence of heart disease in asymptomatic chronic cocaine users. Cardiology 2001;95:25-30.. View abstract.
Rome LA, Lippmann ML, Dalsey WC, et al. Prevalence of cocaine use and its impact on asthma exacerbation in an urban population. Chest 2000;117:1324-9. View abstract.
Sauvain M, Rerat C, Moretti C, et al. A study of the chemical composition of Erythroxylum coca var. coca leaves collected in two ecological regions of Bolivia. J Ethnopharmacol 1997;56:179-91.. View abstract.
Spielvogel H, Rodriguez A, Sempore B, et al. Body fluid homeostasis and cardiovascular adjustments during submaximal exercise: influence of chewing coca leaves. Eur J Appl Physiol Occup Physiol 1997;75(5):400-6. View abstract.
Turner M, McCrory P, Johnston A. Time for tea, anyone? Br J Sports Med 2005;39(10):e37. View abstract.
Vitzthum VJ, von Dornum M, Ellison PT. Brief communication: effect of coca-leaf chewing on salivary progesterone assays. Am J Phys Anthropol 1993;92(4):539-44. View abstract.
Select a condition to view a list of vitamins
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.